2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Small Cell Lung Carcinoma
2
Radiation Injuries
2
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Brain Neoplasms
2
Wilms Tumor
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurotoxicity Syndromes
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Memory Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Interventions
Cyclophosphamide
45
Peripheral Blood Stem Cell Transplantation
43
fludarabine phosphate
42
Mycophenolic Acid
30
Whole-Body Irradiation
27
Cyclosporine
27
Busulfan
26
Tacrolimus
23
Antilymphocyte Serum
23
Methotrexate
20
Etoposide
20
romidepsin
19
Filgrastim
19
Melphalan
16
Radiotherapy
15
Flow Cytometry
15
Vorinostat
13
Methylprednisolone
13
Brentuximab Vedotin
13
Lenalidomide
12
Bexarotene
12
mogamulizumab
11
Psychiatric Rehabilitation
11
Bortezomib
11
Therapeutics
10
Rituximab
10
Gemcitabine
10
fludarabine
9
Polymerase Chain Reaction
9
Biopsy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
Lithium
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts